174 related articles for article (PubMed ID: 7849721)
21. Bruton tyrosine kinase (BTK) in X-linked agammaglobulinemia (XLA).
Vihinen M; Mattsson PT; Smith CI
Front Biosci; 2000 Dec; 5():D917-28. PubMed ID: 11102316
[TBL] [Abstract][Full Text] [Related]
22. Mutation analysis of the gene encoding Bruton's tyrosine kinase in a family with a sporadic case of X-linked agammaglobulinemia reveals three female carriers.
Hagemann TL; Assa'ad AH; Kwan SP
Am J Med Genet; 1995 Nov; 59(2):188-92. PubMed ID: 8588584
[TBL] [Abstract][Full Text] [Related]
23. Bruton's tyrosine kinase mutations in 8 Chinese families with X-linked agammaglobulinemia.
Yip KL; Chan SY; Ip WK; Lau YL
Hum Mutat; 2000 Apr; 15(4):385. PubMed ID: 10737994
[TBL] [Abstract][Full Text] [Related]
24. SSCP at the BTK locus.
Vorechovský I
Hum Mol Genet; 1994 Jun; 3(6):1031. PubMed ID: 7951224
[No Abstract] [Full Text] [Related]
25. The genomic structure of human BTK, the defective gene in X-linked agammaglobulinemia.
Rohrer J; Parolini O; Belmont JW; Conley ME; Parolino O [corrected to Parolini O]
Immunogenetics; 1994; 40(5):319-24. PubMed ID: 7927535
[TBL] [Abstract][Full Text] [Related]
26. Structural basis of SH2 domain mutations in X-linked agammaglobulinemia.
Vihinen M; Nilsson L; Smith CI
Biochem Biophys Res Commun; 1994 Dec; 205(2):1270-7. PubMed ID: 7528500
[TBL] [Abstract][Full Text] [Related]
27. Crystal structure of Bruton's tyrosine kinase domain suggests a novel pathway for activation and provides insights into the molecular basis of X-linked agammaglobulinemia.
Mao C; Zhou M; Uckun FM
J Biol Chem; 2001 Nov; 276(44):41435-43. PubMed ID: 11527964
[TBL] [Abstract][Full Text] [Related]
28. Kinase mutant Btk results in atypical X-linked agammaglobulinaemia phenotype.
Gaspar HB; Ferrando M; Caragol I; Hernandez M; Bertran JM; De Gracia X; Lester T; Kinnon C; Ashton E; Espanol T
Clin Exp Immunol; 2000 May; 120(2):346-50. PubMed ID: 10792386
[TBL] [Abstract][Full Text] [Related]
29. Mutations of Bruton's tyrosine kinase gene in Brazilian patients with X-linked agammaglobulinemia.
Ramalho VD; Oliveira Júnior EB; Tani SM; Roxo Júnior P; Vilela MM
Braz J Med Biol Res; 2010 Sep; 43(9):910-3. PubMed ID: 20721470
[TBL] [Abstract][Full Text] [Related]
30. Identification of Btk mutations in 20 unrelated patients with X-linked agammaglobulinaemia (XLA).
Jin H; Webster AD; Vihinen M; Sideras P; Vorechovsky I; Hammarstróm L; Bernatowska-Matuszkiewicz E; Smith CI; Bobrow M; Vetrie D
Hum Mol Genet; 1995 Apr; 4(4):693-700. PubMed ID: 7633420
[TBL] [Abstract][Full Text] [Related]
31. BTKbase: a database of XLA-causing mutations. International Study Group.
Vihinen M; Cooper MD; de Saint Basile G; Fischer A; Good RA; Hendriks RW; Kinnon C; Kwan SP; Litman GW; Notarangelo LD
Immunol Today; 1995 Oct; 16(10):460-5. PubMed ID: 7576047
[No Abstract] [Full Text] [Related]
32. Structure of the PH domain from Bruton's tyrosine kinase in complex with inositol 1,3,4,5-tetrakisphosphate.
Baraldi E; Djinovic Carugo K; Hyvönen M; Surdo PL; Riley AM; Potter BV; O'Brien R; Ladbury JE; Saraste M
Structure; 1999 Apr; 7(4):449-60. PubMed ID: 10196129
[TBL] [Abstract][Full Text] [Related]
33. X-linked agammaglobulinemia (XLA): a genetic tyrosine kinase (Btk) disease.
Mattsson PT; Vihinen M; Smith CI
Bioessays; 1996 Oct; 18(10):825-34. PubMed ID: 8885720
[TBL] [Abstract][Full Text] [Related]
34. Identification of a new Bruton's tyrosine kinase (BTK) mutation associated with a mild phenotype in a child with X-linked agammaglobulinemia (XLA).
Staehelin F; Kühne T
Clin Lab Haematol; 2000 Apr; 22(2):123-5. PubMed ID: 10792406
[TBL] [Abstract][Full Text] [Related]
35. BTKbase, mutation database for X-linked agammaglobulinemia (XLA).
Vihinen M; Belohradsky BH; Haire RN; Holinski-Feder E; Kwan SP; Lappalainen I; Lehväslaiho H; Lester T; Meindl A; Ochs HD; Ollila J; Vorechovsky I; Weiss M; Smith CI
Nucleic Acids Res; 1997 Jan; 25(1):166-71. PubMed ID: 9016530
[TBL] [Abstract][Full Text] [Related]
36. A novel deletion mutation and structural abnormality in the Bruton's tyrosine kinase gene identified in a Chinese patient with X-linked agammaglobulinemia.
Wang S; Lu Y; Li H; Wang Z; Mo X; Chai Z; Han J
Clin Lab; 2014; 60(5):859-62. PubMed ID: 24839832
[TBL] [Abstract][Full Text] [Related]
37. Molecular and structural characterization of five novel mutations in the Bruton's tyrosine kinase gene from patients with X-linked agammaglobulinemia.
Saha BK; Curtis SK; Vogler LB; Vihinen M
Mol Med; 1997 Jul; 3(7):477-85. PubMed ID: 9260159
[TBL] [Abstract][Full Text] [Related]
38. Missense mutations affecting a conserved cysteine pair in the TH domain of Btk.
Vihinen M; Nore BF; Mattsson PT; Bäckesjö CM; Nars M; Koutaniemi S; Watanabe C; Lester T; Jones A; Ochs HD; Smith CI
FEBS Lett; 1997 Aug; 413(2):205-10. PubMed ID: 9280283
[TBL] [Abstract][Full Text] [Related]
39. Characterization of germline mutations of the gene encoding Bruton's tyrosine kinase in families with X-linked agammaglobulinemia.
Hagemann TL; Rosen FS; Kwan SP
Hum Mutat; 1995; 5(4):296-302. PubMed ID: 7627183
[TBL] [Abstract][Full Text] [Related]
40. Structural basis for X-linked agammaglobulinemia (XLA): mutations at interacting Btk residues R562, W563, and A582.
Maniar HS; Vihinen M; Webster AD; Nilsson L; Smith CI
Clin Immunol Immunopathol; 1995 Sep; 76(3 Pt 2):S198-202. PubMed ID: 7554468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]